Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report

por Igata R, Hori H, Atake K, Katsuki A, Nakamura J
Publicado 2016

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder

por Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y
Publicado 2017

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder

por Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Publicado 2019

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder

por Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R
Publicado 2019